A mass on your kidney is an abnormal growth of tissue, and while the word “mass” sounds alarming, it does not automatically mean cancer. Roughly 20 to 30 percent of kidney masses turn out to be benign, and that number climbs even higher for smaller growths. Most kidney masses (about 61%) are discovered by accident during imaging for an unrelated issue like back pain or an abdominal complaint, so finding one unexpectedly is extremely common.
Size Is the Strongest Clue
The single most important factor in determining whether a kidney mass is dangerous is its size. Nearly half (46%) of kidney masses smaller than 1 centimeter are benign, and only about 2% of those tiny masses are aggressive cancers. As size increases, the picture changes dramatically: for masses larger than 7 centimeters, only 6% are benign and 58% are high-grade cancers. A systematic review confirmed this pattern, showing a steady decline in benign findings from 40% at 1 cm down to 6% above 7 cm.
This size-risk relationship is why doctors treat small and large masses very differently. Masses 4 centimeters or smaller are classified as “small renal masses,” and many of them can be safely monitored rather than immediately removed.
Solid Masses vs. Cystic Masses
Kidney masses fall into two broad categories: solid and cystic (fluid-filled). The distinction matters because each carries different risks.
Solid masses are more concerning overall. When a solid mass lights up with contrast dye on imaging, it needs further evaluation. That said, two common types of solid masses are completely benign. Oncocytomas account for about 10% of surgically removed small kidney masses, and angiomyolipomas make up roughly 7%. Angiomyolipomas often contain fat that shows up clearly on a CT scan, making them relatively easy to identify without surgery. Oncocytomas, unfortunately, look a lot like cancer on imaging and sometimes can only be confirmed after a biopsy or removal.
Cystic masses are graded on a scale called the Bosniak classification, which ranges from I to IV based on how complex they look on imaging. Simple cysts (Bosniak I) have a 0% chance of being cancer and need no follow-up at all. Bosniak II cysts carry a 0 to 6% malignancy risk and are also generally left alone. Bosniak IIF cysts are slightly more complex and carry a 5 to 26% risk, so they require periodic imaging to watch for changes. Bosniak III masses have a 55 to 72% chance of malignancy, and Bosniak IV masses are malignant 91 to 100% of the time. Surgery is typically recommended for categories III and IV.
When It Is Cancer
The most common kidney cancer in adults is renal cell carcinoma (RCC). About 75% of kidney cancers are the clear cell subtype, which is the most aggressive and most likely to spread to the lungs, liver, or bones. Papillary RCC accounts for roughly 10% of cases and has a more variable outlook. Chromophobe RCC makes up about 5% and carries the best prognosis, with only 7% of cases spreading beyond the kidney.
The good news is that when kidney cancer is caught while still confined to the kidney (stages I and II), the five-year survival rate is around 70%. Stage III survival ranges from 30 to 55% depending on how far the tumor has extended. Stage IV, where cancer has spread to distant organs, drops to about 5%. Because most kidney masses are now found incidentally on imaging before they cause symptoms, many are caught early.
How Kidney Masses Are Diagnosed
Most kidney masses first appear on an ultrasound or CT scan. Ultrasound is useful for telling whether a mass is solid or fluid-filled, but it has limited sensitivity for small growths and depends heavily on the technician’s skill. CT with contrast is the workhorse of kidney mass evaluation. A solid-looking mass that measures above a certain density on an unenhanced CT (greater than 70 Hounsfield units) is almost always a benign dense cyst, not a tumor, and may not need further workup.
MRI is particularly helpful for masses that are hard to characterize on CT. It detects contrast enhancement with 100% sensitivity and 94% specificity, making it excellent at distinguishing true tumors from benign cysts. Your doctor may order an MRI if CT results are inconclusive or if you need to avoid the radiation or contrast dye used in CT scans.
When imaging alone can’t give a clear answer, a needle biopsy is an option. A needle is guided through the skin into the mass using imaging for precision. Modern biopsies successfully yield a diagnosis 92% of the time, with sensitivity above 99% for core samples. The risk of a biopsy missing a cancer is very low, though non-diagnostic results do occur in a small percentage of cases and may require a repeat procedure.
Active Surveillance for Small Masses
Not every kidney mass needs immediate surgery. For masses 4 centimeters or smaller, active surveillance (regular imaging to monitor the mass over time) is a well-established option. This is especially relevant for older adults or people with other significant health conditions, where the risks of surgery may outweigh the risks of a slow-growing mass.
During surveillance, doctors watch for signs of progression: growth faster than 0.5 centimeters per year, the mass exceeding 4 centimeters, or any evidence of spread. If any of these occur, treatment is recommended. For masses smaller than 2 centimeters, surveillance is a particularly strong option because these masses have the highest likelihood of being benign and the lowest risk of aggressive behavior. Larger masses above 4 centimeters can sometimes be monitored as well, but they tend to grow faster (4 to 8 millimeters per year) and carry a 4 to 6% risk of spreading, so this approach requires closer attention.
Risk Factors for Kidney Masses
Smoking, obesity, and high blood pressure are the three major modifiable risk factors for kidney cancer. Workers exposed to certain industrial solvents, particularly trichloroethylene, also face elevated risk. On the protective side, higher intake of fruits and vegetables is associated with lower rates of kidney cancer.
Genetics play a meaningful role. Kidney cancer heritability is estimated at 38%, meaning a significant portion of overall risk traces back to inherited factors. About 5 to 8% of kidney cancers are linked to specific inherited gene variants. Having a first-degree relative with kidney cancer roughly doubles your risk, and siblings of affected individuals face an even higher relative risk than parent-child pairs. Younger age at diagnosis is a common signal that a hereditary syndrome may be involved, and people with certain inherited conditions are monitored with different size thresholds for intervention.
What Symptoms to Watch For
Most kidney masses produce no symptoms at all, which is why the majority are found incidentally. When symptoms do appear, they typically include blood in the urine (sometimes visible, sometimes only detectable on a urine test), a dull ache or pain in the side or lower back, or a palpable lump in the abdomen. Some people experience unexplained weight loss, fatigue, or fevers. These symptoms are more common with larger or more advanced masses and are less typical of the small, incidentally discovered growths that make up most diagnoses today.